New prostate cancer radiotherapy aims to cut side effects

This study tests a new way to give radiotherapy for men with intermediate-risk prostate cancer. The goal is to lower the dose to healthy parts of the prostate while boosting the dose to the tumor, using a special MRI-guided machine (MR-linac). Twenty men will take part to see if this approach reduces side effects like urinary and bowel problems, while still controlling the cancer.